Angiogenesis inhibitor	Antineoplastic agent	Phenylurea compound	Protein-tyrosine kinase inhibitor	Pyridine	Vascular endothelial growth factor receptor antagonist
\|	\|	\|	\|	\|	\|

Sorafenib (substance)
	Sorafenib
	sorafenib

Id	422042001
Status	Primitive

Has disposition	Angiogenesis inhibitor
Has disposition	Protein-tyrosine kinase inhibitor
Has disposition	Vascular endothelial growth factor receptor antagonist